A study of the relation between the psychotropic activity and the antagonism to acetylcholine observed for some heterocyclic amino esters and compounds of the phencyclidine series suggests some common molecular structural requirements for their properties.
sential for the interaction, which is based on the electronic properties of the molecules and therefore remains valid for the evaluation of compounds which lack any apparent similarity to acetylcholine. This type of molecular arrangement is shown to be shared by both activators and inhibitors of the acetylcholine receptor discussed here, thus supporting the hypothesis of their binding to a common receptor. The differences in biological activity are attributed to the effect of molecular structural factors which are not commonly included in the molecular arrangement based on the active groups of acetylcholine. The role of such factors is revealed by a study of the observed differences in the cholinergic and psychomimetic activities of related pairs of isomers and enantiomers of the molecules investigated. Structural factors which interfere with the conformational changes occurring in the receptor protein induced by an activator are characterized through differences obtained by the comparative investigation of the activities of the agonist acetate and the antagonist benzilate amino esters of quinuclidine, tropine, and pseudotropine. The same factors are shown in studies of the phencyclidine series to contribute to the antagonism to acetylcholine activity that is closely related to the psychomimetic activity of these drugs in the central nervous system. Similarly, phencyclidine derivatives in which the characteristic acetylcholine-like molecular arrangement is modified by various substitutions are shown to loose both anticholinergic and psychotropic behavior. This close correlation is supported by the identification of molecular regions which will generate the proper molecular arrangement in local anesthetics and morphine, compounds which are known to be involved in cholinergic mechanisms.
The biological response characteristic of acetylcholine-like activity is commonly considered to be the manifestation of a certain intrinsic action, triggered by the binding at a specific receptor (1, 2) . Consequently, antagonistic activity has been interpreted as the possible result of shielding the receptor from interaction with agonists (3) . According to this model, molecular species for which an affinity to the receptor can be Abbreviation: AcCh, acetylcholine.
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established, but which fail to cause the perturbation entailing the biological response, may be expected to exhibit antagonistic properties. The rationalization of both agonistic and antagonistic activities on the molecular level should therefore involve consideration of experimentally determined specific drug-receptor affinity, as well as an evaluation of the factors leading to this interaction.
The psychomimetic activity observed for a series of potent anticholinergic drugs (4) offers the opportunity for a methodical study of the molecular structural factors involved in cholinergic activity. Thus, the changes in basic molecular structure that cause an attenuation of the activity of the strong anticholinergic amino esters of glycolic acid (aminoglycolates) in the central nervous system can be shown to interfere also with the requirements for anticholinergic activity. Since similarity of chemical structure is one of the widely accepted criteria for an agonist-antagonist competition on a common receptor (5, 6) , the possibility of identifying some of the structural features necessary for direct interaction with the cholinergic receptor is of special interest for the consideration of both psychomimetic (e.g., hallucinogenic) and anticholinergic activity. We, however, stress that the similarity should be considered in the broader sense of a similar reactivity pattern characterized by both structural and electronic parameters, as suggested also by Mautner (7) .
The assumption of a common receptor for both agonists and antagonists has sometimes been disputed (8, 9) . However, attempts to verify the existence of separate receptors related to the different modes of action have not produced unambiguous results (10) (11) (12) . On the other hand, the persistent correlation between the structural elements entailing both the psychomimetic and the anticholinergic activity can be shown to hold also for the hallucinogenic drugs of the phencycidine [1-(1-phenylcyclohexyl)-piperdineJ series, which do not even exhibit an atom-to-atom correspondence with the functional groups of acetylcholine (AcCh). The molecular arrangement that represents the standard for the direct interaction with the cholinergic receptor is, however, usually based on the characteristic functional groups of atoms in AcCh-like molecules. The structural requirements for the specific interaction of the phencyclidine derivatives with the cholinergic receptor had, therefore, to be sought in terms of a new form of a specific molecular arrangement. This is chosen to be closer to the representation of the dynamic reactivity of the molecule in the early stages of the recognition by the receptor. Such an interaction can be characterized by the pat- tern of the electrostatic potential which is generated by the molecule in its surroundings. This is considered to represent a map of the interaction sites of the molecules in ionic mechanisms (13) that are relevant to the primary stage of the interaction with the receptor (14) .
Structural requirements for cholinergic activity of amino esters
The structural elements leading to the AcCh-like activity of the psychomimetic drugs of the glycolate series can be con- to those generated by phencyclidine (a) and 3-acetoxy quinuclidine (c). Electrostatic potential maps are calculated analytically (28) for the preferred conformations of AcCh (19) and acetoxy quinuclidine (14) and for the x-ray conformation of phencyclidine (36) . Dotted regions surrounding the nitrogen atom correspond to positive potentials (repulsive towards positive charge). Striated regions represent negative potentials (attractive towards positive charge) generated by the ester oxygen and the aromatic ring. Distance parameter is given to point of minimum potential in AcCh. sidered in terms of the active molecular groups of AcCh (Fig.  1 ). This figure represents the spatial and electronic requirements for the direct interaction of certain defined functional sites in the molecule with the cholinergic receptor (15) . These functional groups form an "AcCh moiety" which is easily identifiable in the molecules of potent anticholinergic amino esters such as atropine, scopolamine, 3-quinuclidinyl benzilate and Ditran (a 30:70 mixture of N-ethyl-3-piperidino and N-ethyl-2-pyrrolidinomethyl phenylcyclopentyl glycolate). It has been shown, on the other hand, that in the absence of the phenyl rings and the hydroxyl group, these molecules turn into agonists of AcCh (15) . Since the AcCh moiety is almost rigid in these molecules, no interference or alteration of the specific structural requirements for interaction with the cholinergic receptor site are to be expected from these changes into amino esters of the acetic acid. The different activity of the resulting species is therefore attributed to factors which influence later stages of the drugreceptor interaction, which follow the earlier stage of receptor recognition.
The AcCh-like activity of some heterocyclic amino esters on isolated smooth muscle is presented in Table 1 . Quantum mechanical calculations of the most potent agonist [S(+)-3-acetoxyquinucidine HCl] (15), and of the least active ones in this series, tropine and pseudotropine. have shown that the AcCh-like activity is related to certain energetically preferred conformations of the molecules, which bring the AcCh-like functional groups into a spatial relationship that corresponds to that of the biologically active species (Fig. 1) Proc. Nat. Acad. Sci. USA 70 (1978) tirely to that of the conformation of AcCh that is prevalent in solution (16) , and that is also considered to be involved in biological activity (17) . See, however ref. 18 . Since the calculated energy surfaces of these agonists have also been shown to be very similar to those of AcCh (15) , it becomes pertinent to rationalize their activity by postulating a direct interaction with the cholinergic receptor, with which these drugs mimic the behavior of the natural agent during all the stages of the reaction. From a detailed investigation of the biological activity of the enantiomeric pairs of the acetate and the benzilate amino esters, respectively, it becomes possible to study the molecular structural factors involved in the transition from such AcCh agonists towards the psychomimetic anticholinergic species. Thus, the S(+) enantiomer of the hydrochloride salt of 3-acetoxy quinuclidine is seen in Table 1 to be a much stronger agonist than the R(-) enantiomer, while the pseudotropine derivative proved to be more potent than that of tropine. The results concerning acetoxy quinuclidine contradict earlier findings by Belleau et al. (19) for the methiodide salt (see also ref. 15 ). But our results present an interesting correlation with the higher anticholinergic potency of (-)-quinuclidyl benzylate compared to its enantiomer, and with the stronger activity of (-)-S-hyoscyamine (the tropine (20) . Since, however, both the spatial and electronic elements of the active molecular groups (Fig. 1 ) must be identical for the two enantiomers of acetoxy quinuclidine, and nearly so for the tropine derivatives, the observed differences in their agonistic activity are attributed to differences in their ability to approach the receptor site and to achieve an unhindered short-range interaction, which is most probably related to a spatial rearrangement of the drug-receptor complex. On the other hand, the requirements for antagonistic activity on a common receptor would be related to the ability of the drugs to approach and "recognize" the various sites of the receptor, but with a different interaction result. Such dynamic results of the interaction at the receptor would be affected by structural elements which are usually not included in the consideration of the active groups, such as the steric effects of the "supporting structure" (21) . This influence of the steric parameters, which stems from the difference in the molecular handedness of the two enantiomers with respect to the receptor, can also be considered to account for differences in the AcCh-like agonistic activity observed for structurally related pairs such as R(+) and S(-) ,8methylacetyl choline (22) , and cis-and trans-2-acetoxycyclopropyltrimethylammonium iodide (23) . It has, however, been observed that the difference in the antagonistic activity of the two enantiomers of j3-methylcholine benzilate is much less pronounced than the difference in the activities of (+) and (-) quinucidinyl benzilate (24) . This may be attributed to the much bulkier supporting structure of the quinuclidine fragment, which interferes with the intrinsic activity of the drug. Such discrepancy in the relative activity of enantiomers of the agonists (acetoxy derivatives) and antagonists (benziloxy derivatives) has sometimes been considered as evidence for the existence of different receptors for the two types of activity (25) . This assumption is, however, unnecessary and neglects the very different reactivity requirements for the two types of molecules. The effective screening of a receptor through direct interaction with its functional sites, as suggested from the undisputed competitive nature of the antagonistic activity, does not necessarily have to be influenced by fine molecular detail in the same manner as the agonistic activity. The assumption of different receptors is thus made obsolete by such considerations as the contribution of steric hindrance to antagonism and the influence of molecular rigidity on conformational changes that are pertinent for the agonistic but not for the antagonistic activity.
The transition from the acetate to the benzilate esters leads to an overall increase in the molecular rigidity and adds hydrophobic groups to the molecule. These structural characteristics, which are commonly accepted to contribute considerably to the antagonistic properties of the drugs, lead to an amplification of the basic antagonistic potential, most likely through the prevention of structural rearrangement in the drug-receptor complex, and by additional binding in peripheral regions of the receptor.
The relation between psychomimetic activity and the cholinergic molecular arrangement Experimental evidence for the anticholinergic activity of the well-known psychomimetic agents of the phencyclidine series is summarized in Table 2 . The competitive nature of the inhibition of acetylcholine activity is indicated experimentally by: (i) the parallel shift in the dose-response curves observed when increasing phencyclidine concentrations in the two isolated organs were studied; and (ii) the reversal of the mydriasis caused by phencyclidine HCl in the intact mammalian eye by either the local application of pilocarpine * HCl or after the local application of tacrine (1,2,3,4-tetrahydro-9-amino acridine). Since the antagonistic effect induced by tacrine has been mentioned as a pertinent experimental support for the relation between anticholinergic and psychomimetic activity (26) , it is important to note that the effect has been found to hold for the phencyclidine series (13) . Thus, 10-20 mg/kg of tacrine (administrated irt-aperitoneally) caused a complete reversal of the hyperactivity induced in mice by phencyclidine (4 mg/kg subcutaneous) or the general anesthesia caused by the drug in guinea pigs (8 mg/kg intraperitoneal).
The antagonistic action of phencyclidines to acetylcholine in peripheral systems is compared with activity of the drugs in the central nervous system (Table 2 ). The biological response in the iris exhibits the best overall correlation with central nervous system activity. The most potent agents in all the studied systems are invariably the phenyl and the 2-thienyl derivatives, while the nitrile derivative is always the least active one. A structural factor which seems to be related to the activity in all the systems is the requirement for the cyclohexyl moiety. This fragment induces in the phencyclidine derivatives the mentioned elements of additional rigidity and hydrophobicity that contribute to the antagonistic activity to AcCh, as for the amino esters (27) . The structural factors which define the interaction pattern of these drugs with the specific sites of the cholinergic receptor must, however, be elucidated with consideration of the established active molecular groups (Fig. 1) . Since the phencyclidine derivatives lack any atom-to-atom resemblance to the functional groups of AcCh-like molecules, the criteria for direct interactionwith the receptor must be based on their ability to mimic the interaction behavior of such functional groups. To this end, maps of the electrostatic potentials (28) surrounding the molecules have been calculated for the molecules and the active fragments studied. The maps can be considered to represent a pattern of interaction channels for the drug approaching the receptor site. The various functional groups required for a direct interaction with the macromolecule have been shown (14) to generate potentials of a characteristic pattern (Fig. 2) , which can therefore be interpreted as the specific interaction pattern of the active group, in contradistinction to the commonly used static approach (Fig. 1) . This new type of concept makes it possible to study the dynamics of the drugreceptor interaction through the changes in the potential pattern which are induced by the oriented approach of the molecules to the simulated sites of the receptor. Fig. 2 Thus, the region of negative potential in the ethynyl derivative has been shown (29) to be located near the triple bond, while in the nitrile derivative it is shifted towards the localization region of the nitrogen lone pair and, therefore, no longer corresponds to the spatial requirements of the molecular arrangements. The same characteristic location and nature of the negative potential region corresponding to a C-C triple bond, mimicking the ester oxygen of AcCh, can also be considered responsible for the strong activity of the muscarinic agonist oxotremorine (30, 31) .
Concluding remarks
A knowledge of the preferred conformation of AcCh-like molecules combined with the ability to calculate and com-pare the electrostatic potentials surrounding active molecules makes it possibfe to identify the AcCh-like interaction in various cholinergic drugs. This allows the extension of this investigation to other compounds i.e., 3-quinuclidinyl benzilate (32) and procaine, which have the common denominators that might generate the AcCh-like molecular arrangement (Fig. 3) . Indeed, local anesthetics like procaine have been shown to act by cholinergic mechanisms (33) . For morphine (34) , in which the molecular structure suggests a similarity to the active molecular arrangement in cholinomimetics (Fig. 3) , more conclusive experimental results should be obtained. The existence of such an AcCh-like structure, even in the broader interactive sense, is, however, not the only requirement for a strong anticholinergic activity. Thus, it seems that the presence of a hydrogen bond donating group and fragments representing regions of T-electron concentration at distances of about 6 ii from the cationic head represent structural factors which also contribute to the buildup of the anticholinergic potency in a basically agonist molecular system (35) .
